CHRISTOPHER VANN

Chief Operating Officer, Autolus Therapeutics

Chris leads the commercial activities for Autolus. An industry veteran with 30 years of experience in both development and business roles, he joined Autolus from Hoffmann-La Roche’s Swiss headquarters. Chris has extensive experience in global lifecycle management as well as implementing commercial strategy at a regional and national level. He currently serves as a Board Member for the Alliance for Regenerative Medicine and is the co-Chair of their European Working Group. He gained his degree in Toxicology and Pharmacology from the School of Pharmacy, University of London.

 LIVE ONLINE

23 September 2021

CATCH UP ON DEMAND